First Time Loading...

HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.14 CAD 4.28% Market Closed
Updated: May 17, 2024

HLS Therapeutics Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

HLS Therapeutics Inc
Income from Continuing Operations Peer Comparison

Comparables:
M
MNX

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
HLS Therapeutics Inc
TSX:HLS
Income from Continuing Operations
-$27.5m
CAGR 3-Years
-22%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
M
Manitex Capital Inc
XTSX:MNX
Income from Continuing Operations
-CA$4.8m
CAGR 3-Years
-97%
CAGR 5-Years
-7%
CAGR 10-Years
-31%

See Also

What is HLS Therapeutics Inc's Income from Continuing Operations?
Income from Continuing Operations
-27.5m USD

Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Income from Continuing Operations amounts to -27.5m USD.

What is HLS Therapeutics Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-2%

Over the last year, the Income from Continuing Operations growth was -17%. The average annual Income from Continuing Operations growth rates for HLS Therapeutics Inc have been -22% over the past three years , -2% over the past five years .